177 related articles for article (PubMed ID: 7283815)
1. Ac2IDU, BVDU, and thymine arabinoside therapy in experimental herpes keratitis.
Hettinger ME; Pavan-Langston D; Park NH; Albert DM; De Clercq E; Lin TS
Arch Ophthalmol; 1981 Sep; 99(9):1618-21. PubMed ID: 7283815
[TBL] [Abstract][Full Text] [Related]
2. (E)-5-(2-bromovinyl)-2'-Deoxyuridine in the treatment of experimental herpes simplex keratitis.
Maudgal PC; De Clercq E; Descamps J; Missotten L; De Somer P; Busson R; Vanderhaeghe H; Verhelst G; Walker RT; Jones AS
Antimicrob Agents Chemother; 1980 Jan; 17(1):8-12. PubMed ID: 7352751
[TBL] [Abstract][Full Text] [Related]
3. Experimental thymidine kinase-deficient HSV-1 keratitis: therapeutic attempts.
Maudgal PC; De Clercq E; Huyghe P
Curr Eye Res; 1987 Apr; 6(4):579-84. PubMed ID: 2953558
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of BVDU ((E)-5-(2-bromovinyl)-2'-deoxyuridine) in the treatment of experimental herpes simplex keratitis in rabbits.
Maudgal PC; De Clercq E; Descamps J; Missotten L
Bull Soc Belge Ophtalmol; 1979; 186():109-18. PubMed ID: 554711
[No Abstract] [Full Text] [Related]
5. Experimental stroma herpes simplex keratitis. Influence of treatment with topical bromovinyldeoxyuridine and trifluridine.
Maudgal PC; De Clercq E; Descamps J; Missotten L; Wijnhoven J
Arch Ophthalmol; 1982 Apr; 100(4):653-6. PubMed ID: 6803747
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of bromovinyldeoxyuridine in the treatment of herpes simplex virus and varicella-zoster virus eye infections.
Maudgal PC; De Clercq E; Missotten L
Antiviral Res; 1984 Oct; 4(5):281-91. PubMed ID: 6335020
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of (E)-5-(2-bromovinyl)-2'-deoxyuridine in the topical treatment of herpes simplex keratitis.
Maudgal PC; Missotten L; De Clercq E; Descamps J; De Meuter E
Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1981; 216(4):261-8. PubMed ID: 7020469
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil (BrVaraU, VaraU) in the treatment of experimental herpes simplex virus type 1 keratitis in rabbits: comparison with (E)-5-(2-bromovinyl)-2'-deoxyuridine (BrVUdR).
Töpke H; Gräf M; Wutzler P; Herrmann G; Reefschläger J
Antiviral Res; 1988 Jul; 9(4):273-80. PubMed ID: 3202622
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of 9-(2-phosphonylmethoxyethyl)adenine in the therapy of TK+ and TK- herpes simplex virus experimental keratitis.
Maudgal PC; De Clercq E
Curr Eye Res; 1991; 10 Suppl():139-42. PubMed ID: 1650660
[TBL] [Abstract][Full Text] [Related]
10. (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine in the therapy of thymidine kinase-positive and -deficient herpes simplex virus experimental keratitis.
Maudgal PC; De Clercq E
Invest Ophthalmol Vis Sci; 1991 May; 32(6):1816-20. PubMed ID: 1851733
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of 5-methoxymethyl-2'-deoxyuridine, 9 beta-D-arabinofuranosyladenine and 5-iodo-2'-deoxyuridine in the treatment of experimental herpes simplex keratitis.
Meldrum JB; Gupta VS; Babiuk LA
Chemotherapy; 1980; 26(1):54-63. PubMed ID: 7353440
[TBL] [Abstract][Full Text] [Related]
12. Acyclic antimetabolite therapy of experimental herpes simplex keratitis.
Pavan-Langston D; Campbell R; Lass J
Am J Ophthalmol; 1978 Nov; 86(5):618-23. PubMed ID: 213976
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of bromovinyldeoxyuridine-related compounds in the treatment of experimental herpes simplex keratitis.
Maudgal PC; De Clercq E
Arch Ophthalmol; 1985 Sep; 103(9):1393-7. PubMed ID: 4038133
[TBL] [Abstract][Full Text] [Related]
14. [Chemotherapy of herpetic infections].
Barinskiĭ IF; L'vov ND; Samoĭlovich EO
Vopr Virusol; 1986; 31(1):6-18. PubMed ID: 3515765
[No Abstract] [Full Text] [Related]
15. Activity of 1-(2'-fluoro-2'-deoxy-beta-D-arabinofuranosyl)thymine against herpes simplex virus in cell cultures and rabbit eyes.
Trousdale MD; Nesburn AB; Su TL; Lopez C; Watanabe KA; Fox JJ
Antimicrob Agents Chemother; 1983 Jun; 23(6):808-13. PubMed ID: 6311085
[TBL] [Abstract][Full Text] [Related]
16. Use of nucleoside analogues in the treatment of herpes simplex virus eye diseases.
Sundmacher R
Metab Pediatr Syst Ophthalmol; 1983; 7(2):89-94. PubMed ID: 6686278
[TBL] [Abstract][Full Text] [Related]
17. Bromovinyldeoxyuridine treatment of herpetic keratitis clinically resistant to other antiviral agents.
Maudgal PC; De Clercq E
Curr Eye Res; 1991; 10 Suppl():193-9. PubMed ID: 1650667
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of (S)-HPMPA against thymidine kinase-deficient herpes simplex virus-keratitis.
Maudgal PC; De Clercq E; Huyghe P
Invest Ophthalmol Vis Sci; 1987 Feb; 28(2):243-8. PubMed ID: 8591903
[TBL] [Abstract][Full Text] [Related]
19. Intentional reactivation of latent ocular herpes infection during BVDU therapy.
Trousdale MD; Robin JB; Willey DE; De Clercq E
Curr Eye Res; 1987 Dec; 6(12):1471-7. PubMed ID: 2827960
[TBL] [Abstract][Full Text] [Related]
20. Herpes simplex keratitis.
Kaufman HE; Centifanto-Fitzgerald YM; Varnell ED
Ophthalmology; 1983 Jun; 90(6):700-6. PubMed ID: 6310466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
